Southern Idaho Health Partners LLC

Southern Idaho Health Partners LLC was paid $9.21M by Medicaid between Jan 2018 and Mar 2024, across 89 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	12,421	$594K
2019	18,589	$1.06M
2020	31,189	$1.54M
2021	36,001	$1.91M
2022	38,858	$2.18M
2023	26,682	$1.63M
2024incomplete	4,694	$296K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	35%	53,643	52,227	$3.18M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	26%	31,052	30,078	$2.42M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	4.6%	4,224	4,220	$423K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	4.3%	3,921	3,918	$398K
95810	Polysomnography; sleep staging with 4 or more additional parameters	3.8%	850	839	$349K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	3.8%	4,604	4,556	$346K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	3.2%	3,295	3,148	$292K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	2.7%	14,165	14,088	$249K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.5%	1,940	1,929	$228K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	2.0%	1,695	1,695	$187K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.7%	2,384	2,342	$156K
90472	Immunization administration, each additional vaccine (list separately)	1.6%	7,067	7,050	$152K

77 more codes

99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.6%	3,719	$147K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.4%	4,173	$130K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	967	$83K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,255	$65K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	1,298	$58K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	720	$52K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	209	$48K
95811		<1%	87	$32K
90473		<1%	994	$17K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,235	$15K
99201		<1%	397	$14K
99173		<1%	1,841	$12K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	119	$12K
90474		<1%	1,011	$12K
0012A		<1%	348	$12K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	739	$11K
99234		<1%	104	$10K
96127		<1%	2,092	$9K
0011A		<1%	308	$9K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	570	$8K
99215	Doctor's office visit, returning patient (complex)	<1%	69	$8K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	172	$7K
69210		<1%	295	$7K
90962		<1%	210	$7K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	40	$5K
0071A		<1%	132	$5K
0072A		<1%	104	$4K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	13	$4K
0002A		<1%	88	$4K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	27	$3K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	50	$3K
90686		<1%	4,795	$3K
90480		<1%	68	$3K
0001A		<1%	64	$3K
99205	Prolong outpt/office vis	<1%	13	$2K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	13	$1K
81002		<1%	348	$946.75
36415	Collection of venous blood by venipuncture	<1%	266	$699.09
59025	Fetal non-stress test	<1%	26	$632.35
99177		<1%	200	$579.08
0124A		<1%	12	$400.00
73630		<1%	28	$351.38
71046	Radiologic examination, chest; 2 views	<1%	26	$338.56
85610		<1%	70	$153.30
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	16	$144.58
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	12	$125.22
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	19	$120.19
90672		<1%	1,266	$68.15
94760		<1%	31	$64.08
90648		<1%	1,869	$11.90
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	14	$9.02
3725F		<1%	70	$4.44
1031F		<1%	12	$3.19
90633		<1%	251	$0.01
90670		0%	1,796	$0.00
1159F		0%	189	$0.00
3078F		0%	203	$0.00
1160F		0%	103	$0.00
90700		0%	12	$0.00
0502F		0%	67	$0.00
90734		0%	24	$0.00
90677		0%	38	$0.00
90723		0%	986	$0.00
90680		0%	798	$0.00
90651		0%	172	$0.00
90656		0%	162	$0.00
3008F		0%	271	$0.00
91301		0%	430	$0.00
1126F		0%	24	$0.00
1036F		0%	101	$0.00
4010F		0%	47	$0.00
3074F		0%	207	$0.00
90688		0%	12	$0.00
90674		0%	26	$0.00
1170F		0%	24	$0.00
Q2036	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)	0%	15	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNEAL, GINA (CREDENTIALING)